The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

13 articles for S Kwon


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
The discovery of potent agonists for GPR88, an orphan GPCR, for the potential treatment of CNS disorders.EBI
Lexicon Pharmaceuticals
Design, synthesis, and evaluation of phenylglycinols and phenyl amines as agonists of GPR88.EBI
Bristol-Myers Squibb
Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors.EBI
University of California
Synthesis and Structure-Activity Relationships of Inhibitors That Target the C-Terminal MEEVD on Heat Shock Protein 90.EBI
University of New South Wales
Discovery of novel heat shock protein (Hsp90) inhibitors based on luminespib with potent antitumor activity.EBI
Seoul National University
Synthesis and biological evaluation of 3-acyl-2-phenylamino-1,4-dihydroquinolin-4(1H)-one derivatives as potential MERS-CoV inhibitors.EBI
Korea Research Institute of Chemical Technology
Identification of Cyanamide-Based Janus Kinase 3 (JAK3) Covalent Inhibitors.EBI
Pfizer
Identification of N-{cis-3-[Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl}propane-1-sulfonamide (PF-04965842): A Selective JAK1 Clinical Candidate for the Treatment of Autoimmune Diseases.EBI
Pfizer
POLQ INHIBITORSBDB
Astrazeneca
NOVEL COMPOUND AND USE THEREOF FOR INHIBITING CHECKPOINT KINASE 2BDB
Arum Therapeutics
Compositions and methods for the prevention and/or treatment of mitochondrial disease, including Friedreich's ataxiaBDB
Stealth Biotherapeutics
Nitrile derivative that acts as inhibitor of dipeptidyl peptidase 1 and use thereofBDB
Haisco Pharmaceuticals
Heterocyclic GSK-3 allosteric modulatorsBDB
Consejo Superior de Investigaciones Cientificas (CSIC)